Decade after $8B deal, Roche offloads InterMune to mysterious specialty pharma

Roche’s $8 billion InterMune acquisition, disclosed a decade ago, is now being handed to a specialty pharmaceutical company.

Cayman Islands-based Legacy Pharma is run by …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Getinge to buy Paragonix organ-preserving tech for up to $477M

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Getinge has agreed to buy

August 23, 2024

COVID, Flu, and RSV: Which Virus Has the Worst Outcomes?

SARS-CoV-2 infection was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022-2023 respiratory illness season, while differences were

January 28, 2025

Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.

The Food and Drug Administration on Friday cleared Eli Lilly’s obesity drug Zepbound as the first treatment for a common sleep disorder in the U.S.

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.